Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BYThe New England journal of medicine

Once-Weekly Mosnodenvir as Dengue Prophylaxis in a Human Infection Model.

14 more authors
7 affiliations
  1. 1Johnson & Johnson, Beerse, Belgium.
  2. 2University of Vermont College of Medicine, Burlington.
  3. 3Johnson & Johnson, Horsham, PA.
  4. 4Johns Hopkins Bloomberg School of Public Health, Baltimore.
  5. 5Johnson & Johnson, San Diego, CA.
  6. 6National Institute of Allergy and Infectious Diseases, Bethesda, MD.
  7. 7Johnson & Johnson, Spring House, PA.

Related

  1. Empirical Antibiotic Initiation for Suspected Early-Onset Neonatal Infection in the Setting of Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis: A Single-Center Retrospective Cohort Study
    Anna Zmelonek-Znamirowska, Grzegorz Świercz, Jakub Mlodawski +2
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Diagnostic performance of the dengue Ag NS1 rapid test in Peruvian adults with suspected dengue virus infection
    Lesly Rivera-Yancce, Jhanet Prado-Cárdenas, Jeel Moya-Salazar +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  3. Association of dengue severity with the serotype of infection: a systematic review and meta-analysis
    Hadrian Jules Ang, Clare McCormack, Christl A. Donnelly +1
    EClinicalMedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Kinetics and specificity of orthoflaviviruses NS1 IgG after Zika virus infection in Yellow fever and dengue immunized individuals: a memory recall hypothesis
    S. Marquine, N. Ayhan, K. M. Meneyrol +9
    medRxivPreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
  5. Serotype-structured force of infection for optimizing dengue vaccine trial design
    L. O. Agasa, F. M. Thuita, T. Achia +3
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
BibTeX
@article{wesenbeeck2026onceweekly,
  title = {{Once-Weekly Mosnodenvir as Dengue Prophylaxis in a Human Infection Model.}},
  author = {Liesbeth Van Wesenbeeck and Freya Rasschaert and Kristen K Pierce and Guillermo Herrera-Taracena and Beulah P Sabundayo and Annemie Buelens and Patricia Lutton and Veerle Van Eygen and Megan McKnight and Kim De Clerck and Isabel Fetter and Xi Fang and Nele Goeyvaerts and Kathleen Callewaert and Sarah Sampson and Jeffrey Mayfield and Oliver Lenz and Sandra De Meyer and Thomas N Kakuda and Helen He and Emérito Amaro-Carambot and Ruxandra Draghia-Akli and Marya Carmolli and Marnix Van Loock and Stephen S Whitehead and Anna P Durbin},
  journal = {The New England journal of medicine},
  year = {2026},
  month = oct,
  doi = {10.1056/nejmc2516395},
  url = {https://europepmc.org/article/MED/42874110},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Once-Weekly Mosnodenvir as Dengue Prophylaxis in a Human Infection Model.
AU  - Liesbeth Van Wesenbeeck
AU  - Freya Rasschaert
AU  - Kristen K Pierce
AU  - Guillermo Herrera-Taracena
AU  - Beulah P Sabundayo
AU  - Annemie Buelens
AU  - Patricia Lutton
AU  - Veerle Van Eygen
AU  - Megan McKnight
AU  - Kim De Clerck
AU  - Isabel Fetter
AU  - Xi Fang
AU  - Nele Goeyvaerts
AU  - Kathleen Callewaert
AU  - Sarah Sampson
AU  - Jeffrey Mayfield
AU  - Oliver Lenz
AU  - Sandra De Meyer
AU  - Thomas N Kakuda
AU  - Helen He
AU  - Emérito Amaro-Carambot
AU  - Ruxandra Draghia-Akli
AU  - Marya Carmolli
AU  - Marnix Van Loock
AU  - Stephen S Whitehead
AU  - Anna P Durbin
PY  - 2026
DA  - 2026/10/01
JO  - The New England journal of medicine
DO  - 10.1056/nejmc2516395
UR  - https://europepmc.org/article/MED/42874110
SN  - 0028-4793
SN  - 1533-4406
ER  -